FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Estradiol Valerate Injection, USP
Status: Currently in Shortage
»Date first posted: 08/10/2016
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Par Pharmaceutical (Reverified 02/09/2017)

Company Contact Information:
201-802-4000

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Delestrogen® (estradiol valerate injection, USP) 10 mg/mL, 5 mL vial: (NDC 42023-110-01) All presentations are currently on backorder. Company working to have this available again as soon as possible Par is the sole source for the 10mg strength. Other
Delestrogen® (estradiol valerate injection, USP) 20 mg/mL, 5 mL vial: (NDC 42023-111-01) All presentations are currently on backorder. Company working to have this available again as soon as possible Par is the sole source for the 10mg strength. Other
Delestrogen® (estradiol valerate injection, USP) 40 mg/mL, 5 mL vial: (NDC 42023-112-01) All presentations are currently on backorder. Company working to have this available again as soon as possible Par is the sole source for the 10mg strength. Other

Perrigo Pharmaceuticals (Revised 03/21/2017)

Company Contact Information:
866-634-9120

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Estradiol Valerate Injection, USP 20 mg/mL, 5 mL vial, (NDC 0574-0870-05) Available Lots releasing in March 2017. Shortage of an inactive ingredient component
Estradiol Valerate Injection, USP 40 mg/mL, 5 mL vial, (NDC 0574-0872-05) Available Lots releasing in March/April/May 2017. Shortage of an inactive ingredient component

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English